A detailed history of Xtx Topco LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 12,892 shares of AXNX stock, worth $915,074. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,892
Holding current value
$915,074
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $867,631 - $898,185
12,892 New
12,892 $898,000
Q1 2024

May 13, 2024

BUY
$56.67 - $69.36 $737,560 - $902,720
13,015 New
13,015 $897,000
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $33,065 - $41,484
689 Added 7.06%
10,455 $527,000
Q1 2023

May 12, 2023

BUY
$52.6 - $67.34 $245,379 - $314,141
4,665 Added 91.45%
9,766 $532,000
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $303,815 - $390,736
5,101 New
5,101 $318,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.